ARTG 476078Novalung kits (XLung kit 230, MiniLung kit 1/4", MiniLung petite) - Cardiopulmonary bypass system tubing set
ARTG ID: 476078 · Fresenius Medical Care Australia Pty Ltd · Xenios AG · Class III · Started January 17, 2025
Good Name: Fresenius Medical Care Australia Pty Ltd - Novalung kits (XLung kit 230, MiniLung kit 1/4", MiniLung petite) - Cardiopulmonary bypass system tubing set
- Risk Class
- Class III
- Product Type
- Procedure Pack
- ARTG Category
- General
- ARTG ID
- 476078
- Start Date
- January 17, 2025
- Effective Date
- January 17, 2025
- Name
- Xenios AG
- Country
- Germany
- Address
- Im Zukunftspark 1, Heilbronn, 74076
The Novalung kit range (XLung, MiniLung, MiniLung petite) is intended for long-term respiratory/cardiopulmonary support through the extracorporeal gas exchange, pumping and thermoregulation of blood in patients with acute respiratory or cardiopulmonary distress or failure
Access comprehensive regulatory information for Novalung kits (XLung kit 230, MiniLung kit 1/4", MiniLung petite) - Cardiopulmonary bypass system tubing set in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class III is registered under ARTG number 476078 and sponsored by Fresenius Medical Care Australia Pty Ltd, manufactured by Xenios AG in Germany. The device registration started on January 17, 2025.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.